NO20062918L - Anvendelse av antibiotika som vaksineadjuvanser - Google Patents
Anvendelse av antibiotika som vaksineadjuvanserInfo
- Publication number
- NO20062918L NO20062918L NO20062918A NO20062918A NO20062918L NO 20062918 L NO20062918 L NO 20062918L NO 20062918 A NO20062918 A NO 20062918A NO 20062918 A NO20062918 A NO 20062918A NO 20062918 L NO20062918 L NO 20062918L
- Authority
- NO
- Norway
- Prior art keywords
- adjuvant
- azalide
- vaccine
- antibiotics
- antimicrobial agent
- Prior art date
Links
- 239000012646 vaccine adjuvant Substances 0.000 title abstract 2
- 229940124931 vaccine adjuvant Drugs 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 5
- 239000004599 antimicrobial Substances 0.000 abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 2
- 239000013566 allergen Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52409703P | 2003-11-21 | 2003-11-21 | |
| PCT/IB2004/003694 WO2005049081A1 (en) | 2003-11-21 | 2004-11-08 | The use of anti biotics as vaccine adjuvants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062918L true NO20062918L (no) | 2006-08-21 |
Family
ID=34619630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062918A NO20062918L (no) | 2003-11-21 | 2006-06-21 | Anvendelse av antibiotika som vaksineadjuvanser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070141086A1 (ru) |
| EP (1) | EP1689434A1 (ru) |
| JP (1) | JP2007512312A (ru) |
| KR (1) | KR100785601B1 (ru) |
| CN (1) | CN1882360A (ru) |
| AR (1) | AR047728A1 (ru) |
| AU (1) | AU2004290982B2 (ru) |
| BR (1) | BRPI0416205A (ru) |
| CA (1) | CA2546195A1 (ru) |
| IL (1) | IL175373A0 (ru) |
| MX (1) | MXPA06005639A (ru) |
| NO (1) | NO20062918L (ru) |
| RU (1) | RU2322241C2 (ru) |
| TW (1) | TW200526245A (ru) |
| WO (1) | WO2005049081A1 (ru) |
| ZA (1) | ZA200603065B (ru) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| MXPA05004278A (es) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Espuma cosmetica y farmaceutica. |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| FR2896416B1 (fr) * | 2006-01-24 | 2010-08-13 | Vetoquinol | Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| MX2010006984A (es) * | 2007-12-21 | 2010-10-25 | Glaxosmithkline Biolog Sa | Vacunas contra la malaria. |
| US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| BR112012007473A2 (pt) | 2009-10-02 | 2019-05-07 | Foamix Ltd | composições tópicas de tetraciclina e respectivo método de uso |
| EP2528620B1 (en) * | 2010-01-28 | 2019-06-05 | Universiteit Gent | Salmonella vaccine |
| EA035513B1 (ru) * | 2011-07-22 | 2020-06-29 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" | ВАКЦИНА, СОДЕРЖАЩАЯ БЕЛОК Als3, ДЛЯ ЛЕЧЕНИЯ У МЛЕКОПИТАЮЩЕГО АБСЦЕССА КОЖИ, ОБУСЛОВЛЕННОГО STAPHYLOCOCCUS AUREUS |
| WO2014152092A2 (en) * | 2013-03-14 | 2014-09-25 | Rongfu Wang | Methods and compositions for modulating regulatory t cell function |
| EA030005B1 (ru) | 2013-03-15 | 2018-06-29 | Лос-Анджелес Биомедикал Ресерч Институт Эт Харбор-Укла Медикал Центер | Композиции и способы лечения грибковых и бактериальных патогенов |
| CN103127098B (zh) * | 2013-03-22 | 2014-05-14 | 于法周 | 一种含有克拉维酸或其盐的抗癌药物组合物及制药用途 |
| EP2926815A1 (en) * | 2014-04-03 | 2015-10-07 | Institut Curie | New derivatives of cephalosporin for treating cancer |
| CN105616414B (zh) * | 2014-10-28 | 2019-03-05 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的新用途 |
| WO2016065525A1 (zh) * | 2014-10-28 | 2016-05-06 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的用途 |
| CN104546863B (zh) * | 2015-02-09 | 2016-09-14 | 江苏澳格姆生物科技有限公司 | 头孢噻吩钠在制备抑制肿瘤细胞转移和扩散的药物中的应用 |
| WO2017022793A1 (ja) * | 2015-08-06 | 2017-02-09 | 日東電工株式会社 | 免疫誘導促進組成物及びワクチン医薬組成物 |
| WO2017116049A1 (ko) * | 2015-12-31 | 2017-07-06 | 경북대학교 산학협력단 | 설폰아마이드계 화합물을 유효성분으로 포함하는 암의 치료 및 전이 억제용 약학적 조성물 |
| US10857216B2 (en) | 2016-03-09 | 2020-12-08 | Novadigm Therapeutics, Inc. | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| CN110302376A (zh) * | 2019-04-22 | 2019-10-08 | 荆门市动物疫病预防控制中心 | 一种禽流感疫苗佐剂及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
| US6339063B1 (en) * | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| UA70972C2 (ru) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членные азалиды и их применение как антибиотиков |
-
2004
- 2004-11-08 CA CA002546195A patent/CA2546195A1/en not_active Abandoned
- 2004-11-08 JP JP2006540643A patent/JP2007512312A/ja not_active Withdrawn
- 2004-11-08 US US10/595,784 patent/US20070141086A1/en not_active Abandoned
- 2004-11-08 WO PCT/IB2004/003694 patent/WO2005049081A1/en active Application Filing
- 2004-11-08 AU AU2004290982A patent/AU2004290982B2/en not_active Expired - Fee Related
- 2004-11-08 RU RU2006117339/15A patent/RU2322241C2/ru not_active IP Right Cessation
- 2004-11-08 EP EP04798833A patent/EP1689434A1/en not_active Withdrawn
- 2004-11-08 KR KR1020067009852A patent/KR100785601B1/ko not_active IP Right Cessation
- 2004-11-08 MX MXPA06005639A patent/MXPA06005639A/es not_active Application Discontinuation
- 2004-11-08 CN CNA2004800341547A patent/CN1882360A/zh active Pending
- 2004-11-08 BR BRPI0416205-6A patent/BRPI0416205A/pt not_active IP Right Cessation
- 2004-11-19 AR ARP040104279A patent/AR047728A1/es not_active Application Discontinuation
- 2004-11-19 TW TW093135705A patent/TW200526245A/zh unknown
-
2006
- 2006-04-18 ZA ZA200603065A patent/ZA200603065B/xx unknown
- 2006-05-01 IL IL175373A patent/IL175373A0/en unknown
- 2006-06-21 NO NO20062918A patent/NO20062918L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2006117339A (ru) | 2007-12-10 |
| US20070141086A1 (en) | 2007-06-21 |
| JP2007512312A (ja) | 2007-05-17 |
| AR047728A1 (es) | 2006-02-15 |
| EP1689434A1 (en) | 2006-08-16 |
| TW200526245A (en) | 2005-08-16 |
| CN1882360A (zh) | 2006-12-20 |
| BRPI0416205A (pt) | 2006-12-26 |
| CA2546195A1 (en) | 2005-06-02 |
| KR100785601B1 (ko) | 2007-12-14 |
| AU2004290982A1 (en) | 2005-06-02 |
| KR20060091001A (ko) | 2006-08-17 |
| RU2322241C2 (ru) | 2008-04-20 |
| ZA200603065B (en) | 2007-08-29 |
| IL175373A0 (en) | 2006-09-05 |
| AU2004290982B2 (en) | 2008-06-19 |
| WO2005049081A1 (en) | 2005-06-02 |
| MXPA06005639A (es) | 2006-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062918L (no) | Anvendelse av antibiotika som vaksineadjuvanser | |
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| BRPI0410503B8 (pt) | composição tópica e uso da composição | |
| HUP0301452A2 (hu) | Fotokemoterápiás szert és mukoadhéziós szert tartalmazó gyógyszerkészítmény és alkalmazása | |
| DK1187629T3 (da) | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid | |
| WO2004087153A3 (en) | Use of organic compounds for immunopotentiation | |
| SE0102315D0 (sv) | Compounds | |
| EA200801275A1 (ru) | Стабилизированные составы карбоната лантана | |
| NO20061911L (no) | Immunogene sammensetninger | |
| ECSP034916A (es) | Oxazolidinonas substituidas para terapia de combinacion | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| AR059203A1 (es) | Composiciones para uso vaginal | |
| EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
| UY28313A1 (es) | Nonadepsipeptidos acilados | |
| AR053775A1 (es) | Nonadepsipeptidos acilados ii | |
| ECSP045397A (es) | 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS | |
| CY1109187T1 (el) | Νεα μακρολιδια | |
| DK1532131T3 (da) | Motilid-forbindelser | |
| TR200401120T4 (tr) | Endoparazit öldürücü jel bileşimi | |
| ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
| NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
| UY28542A1 (es) | Amidas macrocíclicas antibacterianas | |
| CR9073A (es) | Coadministracion de tigeciclina y digoxin | |
| ECSP045405A (es) | Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa | |
| BRPI0412694A (pt) | compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |